Pulmonary vascular disorder affects the blood vessels between your heart and lungs, making it harder for your body to deliver oxygen where it’s needed most. While this condition presents serious challenges, understanding your treatment options—from established medications to innovative therapies being tested in research trials—can help you work with your healthcare team to manage symptoms and maintain the best possible quality of life.

Understanding Your Treatment Journey

When you receive a diagnosis of pulmonary vascular disorder, the main goals of treatment focus on lessening the severity of your symptoms, reducing the strain on your heart, and improving your ability to carry out daily activities. Because this is a complex group of conditions affecting the blood vessels in your lungs, treatment approaches must be carefully tailored to your specific situation^[2].

Your treatment plan will depend on several important factors. These include which type of pulmonary vascular disorder you have, what caused it in the first place, how advanced the condition is, and your overall health status. For example, if your pulmonary vascular disorder developed because of another health problem—such as heart disease, lung disease, or blood clots—managing that underlying condition becomes a critical part of your treatment strategy^[1].

The treatment landscape includes both standard therapies that have been used successfully for years and newer approaches currently being studied in clinical trials. Your healthcare team will work with you to create a personalized plan that addresses your unique needs and circumstances. This might include medications, lifestyle changes, and in some cases, surgical procedures^[9].

Standard Treatment Approaches

The foundation of pulmonary vascular disorder treatment often begins with addressing any underlying conditions that may be causing or worsening the problem. If heart failure is contributing to increased pressure in your lung blood vessels, your doctor will focus on treatments to improve your heart function. Similarly, if lung disease is the culprit, managing that condition becomes essential^[1].

Anticoagulant medicines, commonly known as blood thinners, play an important role in many treatment plans. Medications such as warfarin help prevent blood clots from forming or getting larger. This is especially crucial if your pulmonary vascular disorder involves blockages in the lung arteries. By keeping your blood from clotting too easily, these medications help maintain better blood flow through your lungs^[11].

Diuretics, often called water tablets, help remove excess fluid that builds up in your body. When pulmonary vascular disorder puts extra strain on your heart, fluid can accumulate in your legs, abdomen, or around your lungs. Diuretics help your kidneys remove this extra fluid through urination, which reduces the workload on your heart and can help you breathe more easily^[11].

For patients experiencing low oxygen levels in their blood, home oxygen therapy may be prescribed. This treatment involves breathing air that contains a higher concentration of oxygen than what’s normally in the atmosphere. By ensuring your body gets enough oxygen, this therapy can reduce symptoms like shortness of breath and help your heart work more efficiently^[11].

When pulmonary vascular disorder specifically involves pulmonary arterial hypertension (high blood pressure in the lung arteries), several specialized medications become available. Endothelin receptor antagonists are drugs that block the action of a substance in your body called endothelin, which causes blood vessels to narrow. Medications in this category include bosentan, ambrisentan, and macitentan. By blocking endothelin, these drugs help the arteries in your lungs stay more open and relaxed^[11].

Phosphodiesterase 5 inhibitors, such as sildenafil and tadalafil, work by helping to widen the blood vessels in your lungs. These medications increase levels of a natural substance in your body that causes blood vessel walls to relax, which lowers the pressure inside the lung arteries and makes it easier for blood to flow through^[11].

Prostaglandins are medications that act as powerful blood vessel relaxers. Epoprostenol, iloprost, and treprostinil belong to this category. These drugs mimic natural substances in your body that help keep blood vessels open. Epoprostenol, specifically, requires continuous delivery through a special intravenous catheter. This medication must be mixed daily and kept refrigerated, and patients need to pay very careful attention to catheter care to prevent infections. Common side effects include headache, jaw discomfort, flushing, skin rashes, and upset stomach. Despite these challenges, epoprostenol can significantly improve exercise capacity and survival in patients with advanced disease^[15].

Soluble guanylate cyclase stimulators, such as riociguat, represent another class of medications that help relax the pulmonary arteries. These drugs work through a different pathway than other medications, offering additional treatment options when other therapies aren’t sufficient^[11].

In some carefully selected cases, calcium channel blockers—including nifedipine, diltiazem, nicardipine, and amlodipine—may be used. These medications, which are also used to treat high blood pressure throughout the body, can help relax the smooth muscle in artery walls^[11].

Treatment duration varies considerably depending on the type and severity of your condition. Many patients with pulmonary vascular disorders require long-term medication therapy, sometimes for the rest of their lives. Your doctor will regularly monitor how well your medications are working and adjust your treatment plan as needed. This might involve changing doses, adding new medications, or switching to different drugs if side effects become problematic or if your condition changes^[9].

Side effects can occur with any medication, and it’s important to discuss these with your healthcare team. Some medications may cause headaches, nausea, flushing, or dizziness. Others might require regular blood tests to monitor their effects on your body. Your doctor will help you balance the benefits of treatment against any bothersome side effects, making adjustments when necessary to keep you as comfortable as possible while still managing your condition effectively^[11].

Surgical and Procedural Interventions

When medications alone aren’t enough, or when specific blockages are causing your pulmonary vascular disorder, surgical procedures may become necessary. A pulmonary endarterectomy is an operation designed to remove old blood clots that have lodged in the pulmonary arteries. This procedure is specifically used for patients with chronic thromboembolic pulmonary hypertension, a condition where blood clots that traveled to the lungs never dissolved naturally. By surgically removing these clots, doctors can restore better blood flow through the lung arteries and reduce pressure on the heart^[11].

Balloon pulmonary angioplasty represents a newer, less invasive approach for certain patients. During this procedure, doctors guide a tiny balloon through your blood vessels to the narrowed or blocked areas in your lung arteries. The balloon is then briefly inflated to push the blockage aside and restore blood flow. This technique may be considered when pulmonary endarterectomy isn’t suitable, and research has shown it can lower blood pressure in the lung arteries, improve breathing, and increase your ability to exercise^[11].

For some patients with severe, progressive pulmonary vascular disorder that doesn’t respond adequately to other treatments, lung transplantation may be the only definitive treatment option. This major surgery involves replacing your diseased lung or lungs with healthy ones from a donor. The decision to pursue lung transplantation is complex and involves careful evaluation by a specialized transplant team^[2][9].

Treatment Being Explored in Clinical Trials

Research into pulmonary vascular disorders continues to advance, with scientists and doctors working to develop new therapies that might offer better outcomes or fewer side effects than current treatments. Clinical trials represent the pathway through which these promising new approaches are carefully tested before becoming widely available.

Clinical trials typically progress through three main phases. Phase I trials focus primarily on safety, testing a new drug or treatment in a small group of people to evaluate whether it’s safe enough to continue studying. These trials help researchers determine appropriate dosing and identify any serious side effects. Phase II trials expand the testing to more participants and begin to look at whether the treatment actually works—does it improve symptoms, reduce disease progression, or provide other measurable benefits? Phase III trials involve even larger groups of patients and compare the new treatment directly against current standard treatments to see if the new approach offers advantages.

The field of pulmonary vascular disorder treatment is seeing exploration of several innovative therapeutic approaches. Researchers are investigating new molecules that target specific pathways involved in the disease process. Some experimental treatments focus on reducing inflammation in the blood vessel walls, while others aim to prevent the thickening and stiffening that characterizes diseased pulmonary arteries.

Gene therapy approaches are being studied to see if they can address the underlying genetic factors that contribute to some forms of pulmonary vascular disorder. These experimental treatments attempt to correct or compensate for genetic abnormalities that may cause blood vessels in the lungs to behave abnormally.

Immunotherapy strategies are also under investigation. These approaches harness or modify the body’s immune system to better manage the disease process. Some experimental immunotherapies aim to reduce harmful inflammation in the lung blood vessels, while others try to promote healing and repair of damaged vessel walls.

New types of enzyme inhibitors are being developed and tested. These are molecules designed to block specific enzymes—proteins that trigger chemical reactions in the body—that contribute to the narrowing and stiffening of pulmonary arteries. By inhibiting these enzymes, researchers hope to prevent or slow the progression of vessel damage.

Some clinical trials are testing whether existing medications approved for other conditions might also help patients with pulmonary vascular disorders. This approach, sometimes called drug repurposing, can potentially speed up the availability of new treatment options because these medications have already been proven safe for human use.

Early results from some clinical trials have shown promising signs, such as improvements in exercise capacity, reductions in pulmonary artery pressure, better breathing function, and favorable safety profiles. However, it’s important to remember that not all experimental treatments that show early promise ultimately prove effective in larger, longer-term studies.

Clinical trials for pulmonary vascular disorders are conducted at medical centers around the world, including locations in Europe, the United States, and other regions. Each trial has specific eligibility requirements based on factors such as the type of pulmonary vascular disorder you have, how severe your condition is, what treatments you’ve already tried, and your overall health status. Some trials accept only patients who haven’t yet received certain treatments, while others specifically look for patients whose disease hasn’t responded well to standard therapies.

Participating in a clinical trial offers potential benefits, including access to cutting-edge treatments before they become widely available, close monitoring by specialized medical teams, and the opportunity to contribute to medical knowledge that might help future patients. However, clinical trials also involve uncertainties—the experimental treatment might not work for you, could cause unexpected side effects, or might require more frequent medical visits and testing than standard care^[2].

Most Common Treatment Methods

• Medication Therapy
  • Anticoagulants such as warfarin to prevent blood clots from forming or enlarging in the pulmonary arteries^[11]
  • Diuretics to remove excess fluid that accumulates due to heart strain, reducing workload on the cardiovascular system^[11]
  • Endothelin receptor antagonists including bosentan, ambrisentan, and macitentan to block substances that narrow blood vessels^[11]
  • Phosphodiesterase 5 inhibitors like sildenafil and tadalafil to help widen pulmonary arteries^[11]
  • Prostaglandins such as epoprostenol, iloprost, and treprostinil to relax blood vessel walls^[15]
  • Soluble guanylate cyclase stimulators like riociguat to improve blood vessel relaxation through different pathways^[11]
  • Calcium channel blockers including nifedipine and diltiazem for selected patients^[11]
• Oxygen Therapy
  • Home oxygen treatment to maintain adequate blood oxygen levels and reduce breathing difficulty^[11]
• Surgical Procedures
  • Pulmonary endarterectomy to surgically remove chronic blood clots from lung arteries^[11]
  • Balloon pulmonary angioplasty using minimally invasive techniques to open blocked vessels^[11]
  • Lung transplantation for severe cases not responding to other treatments^[2][9]
• Management of Underlying Conditions
  • Treatment of heart disease, lung disease, or autoimmune conditions that contribute to pulmonary vascular disorder^[1]
• Supportive Care
  • Specialized diagnostic testing and monitoring through pulmonary vascular disease programs^[9]
  • Multidisciplinary team approach involving pulmonologists, cardiologists, and other specialists^[2]